About IP Group

Henry Kay

IP Group CEO Interview - [OLD]

Delivering Impact

Portfolio Examples

Portfolio - Health

IP Group CEO Interview

Long-term growth drivers

Key Differentiators

Chapter 4 Portfolio Health v5.mp4

ASP Isotopes CEO Interview

MEIRAGTx CEO Interview

ASP Isotopes is an isotope enrichment company utilizing technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses. Many of these elements are unsuitable for enrichment using traditional methods such as centrifuges. The Company is initially focused on commercializing Molybdenum 100, which has the potential to replace Molybdenum 99, a commonly used product in the diagnostic imaging market, and Carbon-14, the most frequently used radiolabel for drug discovery, drug metabolism, and pharmacokinetics. Learn more at: https://www.redchip.com/stocks/aspi

IP Group

Section 1

Section 2

Section 3